Global Elotuzumab Market Growth 2022-2028
- LP 4768512
- 72 Pages
- January 2022
- Pharmaceuticals
The United States Elotuzumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Elotuzumab market, reaching US$ million by the year 2028. As for the Europe Elotuzumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Elotuzumab players cover Bristol Myers Squibb, Abbvie, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Elotuzumab market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
300mg Injection
400mg Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Drug Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bristol Myers Squibb
Abbvie
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Elotuzumab Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Elotuzumab by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Elotuzumab by Country/Region, 2017, 2022 & 2028
2.2 Elotuzumab Segment by Type
2.2.1 300mg Injection
2.2.2 400mg Injection
2.3 Elotuzumab Sales by Type
2.3.1 Global Elotuzumab Sales Market Share by Type (2017-2022)
2.3.2 Global Elotuzumab Revenue and Market Share by Type (2017-2022)
2.3.3 Global Elotuzumab Sale Price by Type (2017-2022)
2.4 Elotuzumab Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Drug Center
2.4.4 Other
2.5 Elotuzumab Sales by Application
2.5.1 Global Elotuzumab Sale Market Share by Application (2017-2022)
2.5.2 Global Elotuzumab Revenue and Market Share by Application (2017-2022)
2.5.3 Global Elotuzumab Sale Price by Application (2017-2022)
3 Global Elotuzumab by Company
3.1 Global Elotuzumab Breakdown Data by Company
3.1.1 Global Elotuzumab Annual Sales by Company (2020-2022)
3.1.2 Global Elotuzumab Sales Market Share by Company (2020-2022)
3.2 Global Elotuzumab Annual Revenue by Company (2020-2022)
3.2.1 Global Elotuzumab Revenue by Company (2020-2022)
3.2.2 Global Elotuzumab Revenue Market Share by Company (2020-2022)
3.3 Global Elotuzumab Sale Price by Company
3.4 Key Manufacturers Elotuzumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Elotuzumab Product Location Distribution
3.4.2 Players Elotuzumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Elotuzumab by Geographic Region
4.1 World Historic Elotuzumab Market Size by Geographic Region (2017-2022)
4.1.1 Global Elotuzumab Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Elotuzumab Annual Revenue by Geographic Region
4.2 World Historic Elotuzumab Market Size by Country/Region (2017-2022)
4.2.1 Global Elotuzumab Annual Sales by Country/Region (2017-2022)
4.2.2 Global Elotuzumab Annual Revenue by Country/Region
4.3 Americas Elotuzumab Sales Growth
4.4 APAC Elotuzumab Sales Growth
4.5 Europe Elotuzumab Sales Growth
4.6 Middle East & Africa Elotuzumab Sales Growth
5 Americas
5.1 Americas Elotuzumab Sales by Country
5.1.1 Americas Elotuzumab Sales by Country (2017-2022)
5.1.2 Americas Elotuzumab Revenue by Country (2017-2022)
5.2 Americas Elotuzumab Sales by Type
5.3 Americas Elotuzumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Elotuzumab Sales by Region
6.1.1 APAC Elotuzumab Sales by Region (2017-2022)
6.1.2 APAC Elotuzumab Revenue by Region (2017-2022)
6.2 APAC Elotuzumab Sales by Type
6.3 APAC Elotuzumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Elotuzumab by Country
7.1.1 Europe Elotuzumab Sales by Country (2017-2022)
7.1.2 Europe Elotuzumab Revenue by Country (2017-2022)
7.2 Europe Elotuzumab Sales by Type
7.3 Europe Elotuzumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Elotuzumab by Country
8.1.1 Middle East & Africa Elotuzumab Sales by Country (2017-2022)
8.1.2 Middle East & Africa Elotuzumab Revenue by Country (2017-2022)
8.2 Middle East & Africa Elotuzumab Sales by Type
8.3 Middle East & Africa Elotuzumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Elotuzumab
10.3 Manufacturing Process Analysis of Elotuzumab
10.4 Industry Chain Structure of Elotuzumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Elotuzumab Distributors
11.3 Elotuzumab Customer
12 World Forecast Review for Elotuzumab by Geographic Region
12.1 Global Elotuzumab Market Size Forecast by Region
12.1.1 Global Elotuzumab Forecast by Region (2023-2028)
12.1.2 Global Elotuzumab Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Elotuzumab Forecast by Type
12.7 Global Elotuzumab Forecast by Application
13 Key Players Analysis
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb Elotuzumab Product Offered
13.1.3 Bristol Myers Squibb Elotuzumab Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
14 Research Findings and Conclusion
Table 1. Elotuzumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Elotuzumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 300mg Injection
Table 4. Major Players of 400mg Injection
Table 5. Global Elotuzumab Sales by Type (2017-2022) & (K Pcs)
Table 6. Global Elotuzumab Sales Market Share by Type (2017-2022)
Table 7. Global Elotuzumab Revenue by Type (2017-2022) & ($ million)
Table 8. Global Elotuzumab Revenue Market Share by Type (2017-2022)
Table 9. Global Elotuzumab Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global Elotuzumab Sales by Application (2017-2022) & (K Pcs)
Table 11. Global Elotuzumab Sales Market Share by Application (2017-2022)
Table 12. Global Elotuzumab Revenue by Application (2017-2022)
Table 13. Global Elotuzumab Revenue Market Share by Application (2017-2022)
Table 14. Global Elotuzumab Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global Elotuzumab Sales by Company (2020-2022) & (K Pcs)
Table 16. Global Elotuzumab Sales Market Share by Company (2020-2022)
Table 17. Global Elotuzumab Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Elotuzumab Revenue Market Share by Company (2020-2022)
Table 19. Global Elotuzumab Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers Elotuzumab Producing Area Distribution and Sales Area
Table 21. Players Elotuzumab Products Offered
Table 22. Elotuzumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Elotuzumab Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global Elotuzumab Sales Market Share Geographic Region (2017-2022)
Table 27. Global Elotuzumab Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Elotuzumab Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Elotuzumab Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global Elotuzumab Sales Market Share by Country/Region (2017-2022)
Table 31. Global Elotuzumab Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Elotuzumab Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Elotuzumab Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas Elotuzumab Sales Market Share by Country (2017-2022)
Table 35. Americas Elotuzumab Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Elotuzumab Revenue Market Share by Country (2017-2022)
Table 37. Americas Elotuzumab Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas Elotuzumab Sales Market Share by Type (2017-2022)
Table 39. Americas Elotuzumab Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas Elotuzumab Sales Market Share by Application (2017-2022)
Table 41. APAC Elotuzumab Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC Elotuzumab Sales Market Share by Region (2017-2022)
Table 43. APAC Elotuzumab Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Elotuzumab Revenue Market Share by Region (2017-2022)
Table 45. APAC Elotuzumab Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC Elotuzumab Sales Market Share by Type (2017-2022)
Table 47. APAC Elotuzumab Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC Elotuzumab Sales Market Share by Application (2017-2022)
Table 49. Europe Elotuzumab Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe Elotuzumab Sales Market Share by Country (2017-2022)
Table 51. Europe Elotuzumab Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Elotuzumab Revenue Market Share by Country (2017-2022)
Table 53. Europe Elotuzumab Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe Elotuzumab Sales Market Share by Type (2017-2022)
Table 55. Europe Elotuzumab Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe Elotuzumab Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Elotuzumab Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa Elotuzumab Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Elotuzumab Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Elotuzumab Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Elotuzumab Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Elotuzumab Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Elotuzumab Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa Elotuzumab Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Elotuzumab
Table 66. Key Market Challenges & Risks of Elotuzumab
Table 67. Key Industry Trends of Elotuzumab
Table 68. Elotuzumab Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Elotuzumab Distributors List
Table 71. Elotuzumab Customer List
Table 72. Global Elotuzumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global Elotuzumab Sales Market Forecast by Region
Table 74. Global Elotuzumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Elotuzumab Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Elotuzumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas Elotuzumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Elotuzumab Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC Elotuzumab Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Elotuzumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe Elotuzumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Elotuzumab Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa Elotuzumab Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Elotuzumab Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global Elotuzumab Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Elotuzumab Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Elotuzumab Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Elotuzumab Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global Elotuzumab Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Elotuzumab Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Elotuzumab Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bristol Myers Squibb Basic Information, Elotuzumab Manufacturing Base, Sales Area and Its Competitors
Table 93. Bristol Myers Squibb Elotuzumab Product Offered
Table 94. Bristol Myers Squibb Elotuzumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Bristol Myers Squibb Main Business
Table 96. Bristol Myers Squibb Latest Developments
Table 97. Abbvie Basic Information, Elotuzumab Manufacturing Base, Sales Area and Its Competitors
Table 98. Abbvie Elotuzumab Product Offered
Table 99. Abbvie Elotuzumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. Abbvie Main Business
Table 101. Abbvie Latest Developments
List of Figures
Figure 1. Picture of Elotuzumab
Figure 2. Elotuzumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Elotuzumab Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Elotuzumab Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Elotuzumab Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 300mg Injection
Figure 10. Product Picture of 400mg Injection
Figure 11. Global Elotuzumab Sales Market Share by Type in 2021
Figure 12. Global Elotuzumab Revenue Market Share by Type (2017-2022)
Figure 13. Elotuzumab Consumed in Hospital
Figure 14. Global Elotuzumab Market: Hospital (2017-2022) & (K Pcs)
Figure 15. Elotuzumab Consumed in Clinic
Figure 16. Global Elotuzumab Market: Clinic (2017-2022) & (K Pcs)
Figure 17. Elotuzumab Consumed in Drug Center
Figure 18. Global Elotuzumab Market: Drug Center (2017-2022) & (K Pcs)
Figure 19. Elotuzumab Consumed in Other
Figure 20. Global Elotuzumab Market: Other (2017-2022) & (K Pcs)
Figure 21. Global Elotuzumab Sales Market Share by Application (2017-2022)
Figure 22. Global Elotuzumab Revenue Market Share by Application in 2021
Figure 23. Elotuzumab Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Elotuzumab Revenue Market Share by Company in 2021
Figure 25. Global Elotuzumab Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Elotuzumab Revenue Market Share by Geographic Region in 2021
Figure 27. Global Elotuzumab Sales Market Share by Region (2017-2022)
Figure 28. Global Elotuzumab Revenue Market Share by Country/Region in 2021
Figure 29. Americas Elotuzumab Sales 2017-2022 (K Pcs)
Figure 30. Americas Elotuzumab Revenue 2017-2022 ($ Millions)
Figure 31. APAC Elotuzumab Sales 2017-2022 (K Pcs)
Figure 32. APAC Elotuzumab Revenue 2017-2022 ($ Millions)
Figure 33. Europe Elotuzumab Sales 2017-2022 (K Pcs)
Figure 34. Europe Elotuzumab Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Elotuzumab Sales 2017-2022 (K Pcs)
Figure 36. Middle East & Africa Elotuzumab Revenue 2017-2022 ($ Millions)
Figure 37. Americas Elotuzumab Sales Market Share by Country in 2021
Figure 38. Americas Elotuzumab Revenue Market Share by Country in 2021
Figure 39. United States Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Elotuzumab Sales Market Share by Region in 2021
Figure 44. APAC Elotuzumab Revenue Market Share by Regions in 2021
Figure 45. China Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Elotuzumab Sales Market Share by Country in 2021
Figure 52. Europe Elotuzumab Revenue Market Share by Country in 2021
Figure 53. Germany Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Elotuzumab Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Elotuzumab Revenue Market Share by Country in 2021
Figure 60. Egypt Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Elotuzumab Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Elotuzumab in 2021
Figure 66. Manufacturing Process Analysis of Elotuzumab
Figure 67. Industry Chain Structure of Elotuzumab
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
